Advisory Panel Votes Against Once-Weekly Insulin for T1D
A majority of the advisory committee voted that the benefits of insulin icodec don't outweigh the increased risk of hypoglycemia in type 1 diabetes.
Medscape Medical News
source https://www.medscape.com/viewarticle/advisory-panel-votes-against-once-weekly-insulin-type-1-2024a10009we?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/advisory-panel-votes-against-once-weekly-insulin-type-1-2024a10009we?src=rss
Comments
Post a Comment